BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37327147)

  • 1. Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis.
    Reynolds RA; Aum DJ; Gonzalez-Gomez I; Wong M; Roberts K; Dahiya S; Rodriguez LF; Roland JL; Smyth MD
    J Neurosurg Pediatr; 2023 Sep; 32(3):351-357. PubMed ID: 37327147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology.
    Fohlen M; Harzallah I; Polivka M; Giuliano F; Pons L; Streichenberger N; Dorfmüller G; Touraine R
    Childs Nerv Syst; 2020 May; 36(5):961-965. PubMed ID: 32103336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report.
    Beaumont TL; Godzik J; Dahiya S; Smyth MD
    J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma.
    Sasaki T; Uda T; Kuki I; Kunihiro N; Okazaki S; Niida Y; Goto T
    Childs Nerv Syst; 2022 Jan; 38(1):77-83. PubMed ID: 34741623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report.
    Konakondla S; Jayarao M; Skrade J; Giannini C; Workman MJ; Morgan CJ
    Clin Neurol Neurosurg; 2016 Nov; 150():177-180. PubMed ID: 27690251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
    Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
    Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
    Ichikawa T; Niida Y
    No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.
    Kotulska K; Borkowska J; Mandera M; Roszkowski M; Jurkiewicz E; Grajkowska W; Bilska M; Jóźwiak S
    Childs Nerv Syst; 2014 Dec; 30(12):2037-42. PubMed ID: 25227171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
    Jansen AC; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC
    Front Neurol; 2019; 10():705. PubMed ID: 31333563
    [No Abstract]   [Full Text] [Related]  

  • 10. Solitary subependymal giant cell astrocytoma: Case report and review of the literature.
    Corlette L; Reid A; Roberts-Thomson S; Christie M; Gaillard F
    J Clin Neurosci; 2020 Dec; 82(Pt A):26-28. PubMed ID: 33317733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case.
    Shelley I; Mahtabfar A; Farrell CJ
    J Neurosurg Case Lessons; 2023 Jun; 5(25):. PubMed ID: 37354433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.
    Kuzniewska B; Sadowski K; Urbanska K; Urbanska M; Kotulska K; Liszewska E; Grajkowska W; Jóźwiak S; Dziembowska M
    Folia Neuropathol; 2018; 56(3):167-174. PubMed ID: 30509037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.
    Gao C; Zabielska B; Jiao F; Mei D; Wang X; Kotulska K; Jozwiak S
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation.
    Tang X; Angst G; Haas M; Yang F; Wang C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent
    Bongaarts A; Giannikou K; Reinten RJ; Anink JJ; Mills JD; Jansen FE; Spliet GMW; den Dunnen WFA; Coras R; Blümcke I; Paulus W; Scholl T; Feucht M; Kotulska K; Jozwiak S; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Söylemezoğlu F; Pimentel J; Nellist M; Schouten-van Meeteren AYN; Nag A; Mühlebner A; Kwiatkowski DJ; Aronica E
    Oncotarget; 2017 Nov; 8(56):95516-95529. PubMed ID: 29221145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration.
    Suzuki M; Kondo A; Ogino I; Akiyama O; Fujita N; Shimizu Y; Arai H
    Childs Nerv Syst; 2021 Apr; 37(4):1357-1362. PubMed ID: 32725466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
    Giannikou K; Zhu Z; Kim J; Winden KD; Tyburczy ME; Marron D; Parker JS; Hebert Z; Bongaarts A; Taing L; Long HW; Pisano WV; Alexandrescu S; Godlewski B; Nellist M; Kotulska K; Jozwiak S; Roszkowski M; Mandera M; Thiele EA; Lidov H; Getz G; Devinsky O; Lawrence MS; Ligon KL; Ellison DW; Sahin M; Aronica E; Meredith DM; Kwiatkowski DJ
    Mod Pathol; 2021 Feb; 34(2):264-279. PubMed ID: 33051600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
    Cheng S; Hawkins C; Taylor MD; Bartels U
    Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.